BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  Chang Gung Memorial Hospital Unveils Cellular Therapy: A Beacon of Hope for Cancer Treatment

  October 21, 2024

   · 

  3 min read
• Press Releases

  ViaNautis Appoints Ray Jupp as Chief Scientific Officer

  October 21, 2024

   · 

  3 min read
• News

  Cerevance Announces Publication of Positive Phase 2 Results of Solengepras for the Treatment of Parkinson’s Disease in eClinicalMedicine

  October 21, 2024

   · 

  5 min read
• News

  Amneal Receives U.S. FDA Approval of New Drug Application for Pyridostigmine Bromide Extended-Release Tablets

  October 21, 2024

   · 

  4 min read
• News

  enGene Appoints Joan Connolly as Chief Technology Officer and Anthony Cheung, Ph.D., as Chief Scientific Officer

  October 21, 2024

   · 

  5 min read
• Press Releases

  Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 2, 2024

  October 21, 2024

   · 

  2 min read
• News

  Innocan Pharma to Present at the 2024 ThinkEquity Conference

  October 21, 2024

   · 

  4 min read
• News

  Epitel Expands AI Portfolio With A Fourth FDA 510(k) Clearance for REMI

  October 21, 2024

   · 

  5 min read
• Press Releases

  Quantum BioPharma Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing

  Christian Attar Law Firm and Freedman Normand Friedland LLP, in conjunction with forensic investigators, have uncovered evidence of a potential multi-year market manipulation scheme that has caused substantial damages to the Company and its shareholders

  October 21, 2024

   · 

  10 min read
• News

  Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)

  October 21, 2024

   · 

  4 min read